Kurilensoside H

(1R,2R,5S,6S,8S,9R,11S,12S,13R,14R,15R,16R)-15-[(2R,6S)-7-hydroxy-6-methylheptan-2-yl]-2,16-dimethyl-5-[(2S,3S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadecane-9,11,13,14-tetrol

SOVMHZODGWLPJC-MTTQTYBGSA-N CHEBI:186822 0 Reactome links 4 studies
4 Observed studies
5 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
SOVMHZODGWLPJC-MTTQTYBGSA-N
IUPAC name
(1R,2R,5S,6S,8S,9R,11S,12S,13R,14R,15R,16R)-15-[(2R,6S)-7-hydroxy-6-methylheptan-2-yl]-2,16-dimethyl-5-[(2S,3S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadecane-9,11,13,14-tetrol
Preferred name
Kurilensoside H
INN name
Synonym
ChEBI
CHEBI:186822

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles